Education
About Us
Working with TipRanks
Follow Us
Telo Genomics Corp (TSE:TELO)
:TELO
TELO Stock Chart & Stats
C$0.04
C$0.01(8.00%)
At close: 4:00 PM EST
C$0.04
C$0.01(8.00%)
Day’s Range― - ―
52-Week RangeC$0.05 - C$0.16
Previous CloseN/A
Volume60.50K
Average Volume (3M)29.30K
Market Cap
C$5.30M
Enterprise ValueC$10.25M
Total Cash (Recent Filing)C$1.25M
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta0.38
Next Earnings
Mar 03, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding100,018,936
10 Day Avg. Volume22,350
30 Day Avg. Volume29,304
Financial Highlights & Ratios
PEG Ratio0.26
Price to Book (P/B)22.38
Price to Sales (P/S)0.00
P/FCF Ratio-5.36
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Telo Genomics Corp News
TELO FAQ
What was Telo Genomics Corp’s price range in the past 12 months?
Telo Genomics Corp lowest stock price was C$0.04 and its highest was C$0.16 in the past 12 months.
What is Telo Genomics Corp’s market cap?
Telo Genomics Corp’s market cap is C$5.30M.
When is Telo Genomics Corp’s upcoming earnings report date?
Telo Genomics Corp’s upcoming earnings report date is Mar 03, 2026 which is in 89 days.
How were Telo Genomics Corp’s earnings last quarter?
Currently, no data Available
Is Telo Genomics Corp overvalued?
According to Wall Street analysts Telo Genomics Corp’s price is currently Overvalued.
Does Telo Genomics Corp pay dividends?
Telo Genomics Corp does not currently pay dividends.
What is Telo Genomics Corp’s EPS estimate?
Telo Genomics Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Telo Genomics Corp have?
Telo Genomics Corp has 100,018,936 shares outstanding.
What happened to Telo Genomics Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Telo Genomics Corp?
Currently, no hedge funds are holding shares in TSE:TELO
Company Description
Telo Genomics Corp
Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides telomere analysis platform with diagnostic and prognostic applications; and solutions with liquid biopsies and related technologies in oncology and neurological diseases. The company's lead application is Telo-MM, a solution that provides actionable information to medical professionals in the treatment of Multiple Myeloma, a form of blood cancer. Its solutions also include TeloView, a proprietary software platform used to quantify specific features of each patient's telomeres. The company serves pathologists, clinicians, academic researchers, and drug developers. Telo Genomics Corp. has a collaboration agreement with the Mayo Clinic to validate its Telo-MM tests for multiple myeloma. The company was formerly known as 3D Signatures Inc. and changed its name to Telo Genomics Corp. in April 2019. Telo Genomics Corp. was incorporated in 2014 and is headquartered in Toronto, Canada.
Technical Analysis
BioMark Diagnostics
―
―
StageZero Life Sciences Ltd
―
Avricore Health
―
Izotropic
―
Options Prices
Currently, No data available
---